BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 7678397)

  • 1. Targeted radionuclide therapy for bone metastases.
    Lewington VJ
    Eur J Nucl Med; 1993 Jan; 20(1):66-74. PubMed ID: 7678397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pain palliation and nuclear medicine.
    McEwan AJ
    Eur J Nucl Med; 1993 Jan; 20(1):1-3. PubMed ID: 7678395
    [No Abstract]   [Full Text] [Related]  

  • 3. EANM procedure guidelines for treatment of refractory metastatic bone pain.
    Silberstein EB; Taylor AT;
    Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):BP7-11. PubMed ID: 12723557
    [No Abstract]   [Full Text] [Related]  

  • 4. Radionuclides for metastatic bone pain palliation: a need for rational re-evaluation in the new millennium.
    Krishnamurthy GT; Krishnamurthy S
    J Nucl Med; 2000 Apr; 41(4):688-91. PubMed ID: 10768570
    [No Abstract]   [Full Text] [Related]  

  • 5. Unsealed source therapy of painful bone metastases: an update.
    McEwan AJ
    Semin Nucl Med; 1997 Apr; 27(2):165-82. PubMed ID: 9144858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Radionuclide therapy for painful bone metastases].
    Szefer J; Zuchora Z
    Wiad Lek; 2004; 57(5-6):280-3. PubMed ID: 15518077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone refractory prostatic cancer: the role of radiolabelled diphosphonates and growth factor inhibitors.
    Scher HI; Curley T; Yeh S; Tong W; O'Moore PV; Larson S
    Adv Exp Med Biol; 1992; 324():115-29. PubMed ID: 1283494
    [No Abstract]   [Full Text] [Related]  

  • 8. Radionuclide therapy for painful bone metastases. An Italian multicentre observational study. Writing Committee of an Ad Hoc Study Group.
    Piffanelli A; Dafermou A; Giganti M; Colamussi P; Pizzocaro C; Bestagno M;
    Q J Nucl Med; 2001 Mar; 45(1):100-7. PubMed ID: 11456368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rhenium-186(Sn)HEDP for treatment of painful osseous metastases: results of a double-blind crossover comparison with placebo.
    Maxon HR; Schroder LE; Hertzberg VS; Thomas SR; Englaro EE; Samaratunga R; Smith H; Moulton JS; Williams CC; Ehrhardt GJ
    J Nucl Med; 1991 Oct; 32(10):1877-81. PubMed ID: 1717669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 186Re-etidronate. Efficacy of palliative radionuclide therapy for painful bone metastases.
    Han SH; De Klerk JM; Zonnenberg BA; Tan S; Van Rijk PP
    Q J Nucl Med; 2001 Mar; 45(1):84-90. PubMed ID: 11456380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in our understanding of the treatment of painful bone metastasis.
    Siberstein EB
    J Nucl Med; 2000 Apr; 41(4):655-7. PubMed ID: 10809605
    [No Abstract]   [Full Text] [Related]  

  • 12. [Metabolic radiotherapy: what role will it have in 2001?].
    George B; Douard MC; Rain JD
    Cancer Radiother; 2002 May; 6(3):188-200. PubMed ID: 12116845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New research developments increase therapeutic options for thyroid cancer and bone pain palliation.
    Williams JE
    J Nucl Med; 1997 Nov; 38(11):19N-20N, 26N. PubMed ID: 9374327
    [No Abstract]   [Full Text] [Related]  

  • 14. Re-186 HEDP treatment in breast cancer patients with bone metastases.
    Koutsikos J; Leondi A
    J Natl Med Assoc; 2008 Apr; 100(4):447. PubMed ID: 18481487
    [No Abstract]   [Full Text] [Related]  

  • 15. The management of painful bone metastases with an emphasis on radionuclide therapy.
    Hillegonds DJ; Franklin S; Shelton DK; Vijayakumar S; Vijayakumar V
    J Natl Med Assoc; 2007 Jul; 99(7):785-94. PubMed ID: 17668645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of rhenium-188, rhenium-186-HEDP and strontium-89 in palliation of painful bone metastases].
    Liepe K; Franke WG; Kropp J; Koch R; Runge R; Hliscs R
    Nuklearmedizin; 2000 Sep; 39(6):146-51. PubMed ID: 11057405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Samarium-153 lexidronam for painful bone metastases.
    Med Lett Drugs Ther; 1997 Aug; 39(1008):83-4. PubMed ID: 9286284
    [No Abstract]   [Full Text] [Related]  

  • 18. [Palliation of bone pain in metastatic prostate carcinoma. Value of radionuclide therapy with rhenium 186 HEDP].
    Klutmann S; Bohuslavizki KH
    MMW Fortschr Med; 1999 Nov; 141(44):38-9. PubMed ID: 10912142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ESR dosimetry of 89Sr and 153Sm in bone.
    Kinoshita A; Braga FJ; Graeff CF; Baffa O
    Appl Radiat Isot; 2001 Feb; 54(2):269-74. PubMed ID: 11200888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 186Re-etidronate in breast cancer patients with metastatic bone pain.
    Han SH; Zonneberg BA; de Klerk JM; Quirijnen JM; van het Schip AD; van Dijk A; Blijham GH; van Rijk PP
    J Nucl Med; 1999 Apr; 40(4):639-42. PubMed ID: 10210223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.